title: Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.
abstract: The morphological interpretation of histologic sections forms the basis of diagnosis and prognostication for cancer. In the diagnosis of carcinomas, pathologists perform a semiquantitative analysis of a small set of morphological features to determine the cancer's histologic grade. Physicians use histologic grade to inform their assessment of a carcinoma's aggressiveness and a patient's prognosis. Nevertheless, the determination of grade in breast cancer examines only a small set of morphological features of breast cancer epithelial cells, which has been largely unchanged since the 1920s. A comprehensive analysis of automatically quantitated morphological features could identify characteristics of prognostic relevance and provide an accurate and reproducible means for assessing prognosis from microscopic image data. We developed the C-Path (Computational Pathologist) system to measure a rich quantitative feature set from the breast cancer epithelium and stroma (6642 features), including both standard morphometric descriptors of image objects and higher-level contextual, relational, and global image features. These measurements were used to construct a prognostic model. We applied the C-Path system to microscopic images from two independent cohorts of breast cancer patients [from the Netherlands Cancer Institute (NKI) cohort, n = 248, and the Vancouver General Hospital (VGH) cohort, n = 328]. The prognostic model score generated by our system was strongly associated with overall survival in both the NKI and the VGH cohorts (both log-rank P ≤ 0.001). This association was independent of clinical, pathological, and molecular factors. Three stromal features were significantly associated with survival, and this association was stronger than the association of survival with epithelial characteristics in the model. These findings implicate stromal morphologic structure as a previously unrecognized prognostic determinant for breast cancer.
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Beck
authors.forename: Ankur R
authors.initials: AR
authors.lastname: Sangoi
authors.forename: Samuel
authors.initials: S
authors.lastname: Leung
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Marinelli
authors.forename: Torsten O
authors.initials: TO
authors.lastname: Nielsen
authors.forename: Marc J
authors.initials: MJ
authors.lastname: van de Vijver
authors.forename: Robert B
authors.initials: RB
authors.lastname: West
authors.forename: Matt
authors.initials: M
authors.lastname: van de Rijn
authors.forename: Daphne
authors.initials: D
authors.lastname: Koller
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology*; D002170:Canada; D019992:Databases as Topic; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D009426:Netherlands; D011379:Prognosis; D015203:Reproducibility of Results; D012984:Software; D017154:Stromal Cells / Q000473:pathology*